
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Accurately determining a company’s long-term prospects isn’t easy, especially when sentiment is weak. That’s where StockStory comes in - to help you find attractive investment candidates backed by unbiased research. That said, here are three stocks facing legitimate challenges and some alternatives worth exploring instead.
Tenable (TENB)
Consensus Price Target: $28.85 (6.3% implied return)
Starting with the widely-used Nessus vulnerability scanner first released in 1998, Tenable (NASDAQ: TENB) provides exposure management solutions that help organizations identify, assess, and prioritize cybersecurity vulnerabilities across their IT infrastructure and cloud environments.
Why Is TENB Not Exciting?
- Products, pricing, or go-to-market strategy may need some adjustments as its 6.9% average billings growth over the last year was weak
- Estimated sales growth of 6.8% for the next 12 months implies demand will slow from its two-year trend
- Operating profits and efficiency rose over the last year as it benefited from some fixed cost leverage
Tenable’s stock price of $27.15 implies a valuation ratio of 2.9x forward price-to-sales. If you’re considering TENB for your portfolio, see our FREE research report to learn more.
Procter & Gamble (PG)
Consensus Price Target: $163.43 (9.2% implied return)
Founded by candle maker William Procter and soap maker James Gamble, Procter & Gamble (NYSE: PG) is a consumer products behemoth whose product portfolio spans everything from facial tissues to laundry detergent to feminine care to men’s grooming.
Why Do We Think Twice About PG?
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 2.8%
- Free cash flow margin didn’t grow over the last year
Procter & Gamble is trading at $149.64 per share, or 21.5x forward P/E. Dive into our free research report to see why there are better opportunities than PG.
Simmons First National (SFNC)
Consensus Price Target: $23.57 (4.7% implied return)
With roots dating back to 1903 and a presence across Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas, Simmons First National (NASDAQ: SFNC) is a regional bank holding company that provides banking and financial services to individuals and businesses.
Why Do We Pass on SFNC?
- Annual net interest income growth of 4% over the last five years was below our standards for the banking sector
- Anticipated 17.8 percentage point rise in its efficiency ratio suggests its expenses will increase as a percentage of revenue
- Earnings per share fell by 4% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
At $22.51 per share, Simmons First National trades at 0.9x forward P/B. To fully understand why you should be careful with SFNC, check out our full research report (it’s free).
Stocks We Like More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.